Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | QRFPR | Q96P65 | 3/20 | 0.41 |
| ▸ | TGFBR1 | P36897 | 3/20 | 0.40 |
| ▸ | NMT1 | P30419 | 4/20 | 0.39 |
| ▸ | NMT2 | O60551 | 3/20 | 0.39 |
| ▸ | MME | P08473 | 4/20 | 0.37 |
| ▸ | TERT | O14746 | 1/20 | 0.37 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.36 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.36 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.35 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29828566 | 1.00 | QRFPR (0.41) | QRFPRTGFBR1NMT1NMT2MME | |
| SCHEMBL31383401 | 1.00 | QRFPR (0.41) | QRFPRTGFBR1NMT1NMT2MME | |
| SCHEMBL30220824 | 0.98 | QRFPR (0.42) | QRFPRTGFBR1NMT1NMT2MME | |
| SCHEMBL30956646 | 0.97 | TGFBR1 (0.40) | QRFPRTGFBR1NMT1NMT2MME | |
| SCHEMBL30956647 | 0.97 | TGFBR1 (0.40) | QRFPRTGFBR1NMT1NMT2MME | |
| SCHEMBL30988909 | 0.97 | TGFBR1 (0.40) | QRFPRTGFBR1NMT1NMT2MME | |
| SCHEMBL31423993 | 0.97 | TGFBR1 (0.40) | QRFPRTGFBR1NMT1NMT2MME | |
| SCHEMBL31424011 | 0.97 | TGFBR1 (0.40) | QRFPRTGFBR1NMT1NMT2MME | |
| SCHEMBL1635449 | 0.97 | TGFBR1 (0.42) | QRFPRTGFBR1NMT1NMT2MME | |
| SCHEMBL17874144 | 0.97 | TGFBR1 (0.42) | QRFPRTGFBR1NMT1NMT2MME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250369983-A1 | COMPOSITIONS AND METHODS FOR OPTIMIZED IGG PRODUCTION | ABBRATECH INC (US) | 2025-12-04 | — | — | US | disclosed |
| EP-4656203-A1 | COMPOSITIONS AND METHODS FOR OPTIMIZED IGG PRODUCTION | Abbratech Inc. (US) | 2025-12-03 | — | — | EP | disclosed |
| EP-4602066-A2 | COMPOSITIONS AND METHODS FOR MAKING PAN-VARIANT ANTIBODIES | Abbratech Inc. (US) | 2025-08-20 | — | — | EP | disclosed |
| WO-2024081621-A2 | COMPOSITIONS AND METHODS FOR MAKING PAN-VARIANT ANTIBODIES | ABBRATECH INC. (US) | 2024-04-18 | — | — | WO | disclosed |